Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This is a Phase II, open-label trial of Taxotere® + ZD1839 in elderly patients with Stage
III-b or IV NSCLC who have received no prior chemotherapy for metastatic disease. Patients
with prior adjuvant chemotherapy were allowed to enroll on this trial.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute